Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Oksenhendler

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
Current Opinion in HIV and AIDS|April 7, 2009
HIV-associated multicentric Castleman diseaseEric Oksenhendler
La Revue Du Praticien|December 18, 2007
[Common variable immunodeficiency]Eric Oksenhendler, Claire Fieschi
Current Opinion in Oncology|July 15, 2022
HHV-8 associated lymphomaEric Oksenhendler, Véronique Meignin
Blood|January 6, 2019
Kaposi sarcoma-associated herpesvirus/human herpesvirus 8-associated lymphoproliferative disordersEric Oksenhendler, David Boutboul, Lionel Galicier
Annales De Pathologie|October 3, 2022
[Castleman disease]Véronique Meignin, Julien Calvani, Eric Oksenhendler
Blood|May 25, 2004
Failure of cidofovir in HIV-associated multicentric Castleman diseaseAlice Berezne, Félix Agbalika, Eric Oksenhendler
British Journal of Haematology|March 18, 2008
Bortezomib (PS-341) in patients with human herpesvirus 8-associated primary effusion lymphomaEmmanuelle Boulanger, Véronique Meignin, Eric Oksenhendler
Journal of Acquired Immune Deficiency Syndromes (1999)|July 24, 2012
No evidence for an early excess incidence of progressive multifocal leukencephalopathy in HIV-infected patients treated with rituximabChristian Hoffmann, Laurence Gérard, Christoph Wyen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 7, 2015
The ratio of mean daily IgG increment/mean daily dose in immunoglobulin replacement therapy in primary antibody deficienciesMary Lucas, Martin Lee, Eric Oksenhendler, et al.
Presse Medicale (Paris, France : 1983)|May 20, 2006
[Adult-onset primary hypogammaglobulinemia]Claire Fieschi, Marion Malphettes, Lionel Galicier, et al.
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
Current Opinion in HIV and AIDS|April 7, 2009
HIV-associated multicentric Castleman diseaseEric Oksenhendler
La Revue Du Praticien|December 18, 2007
[Common variable immunodeficiency]Eric Oksenhendler, Claire Fieschi
Current Opinion in Oncology|July 15, 2022
HHV-8 associated lymphomaEric Oksenhendler, Véronique Meignin
Blood|January 6, 2019
Kaposi sarcoma-associated herpesvirus/human herpesvirus 8-associated lymphoproliferative disordersEric Oksenhendler, David Boutboul, Lionel Galicier
Annales De Pathologie|October 3, 2022
[Castleman disease]Véronique Meignin, Julien Calvani, Eric Oksenhendler
Blood|May 25, 2004
Failure of cidofovir in HIV-associated multicentric Castleman diseaseAlice Berezne, Félix Agbalika, Eric Oksenhendler
British Journal of Haematology|March 18, 2008
Bortezomib (PS-341) in patients with human herpesvirus 8-associated primary effusion lymphomaEmmanuelle Boulanger, Véronique Meignin, Eric Oksenhendler
Journal of Acquired Immune Deficiency Syndromes (1999)|July 24, 2012
No evidence for an early excess incidence of progressive multifocal leukencephalopathy in HIV-infected patients treated with rituximabChristian Hoffmann, Laurence Gérard, Christoph Wyen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 7, 2015
The ratio of mean daily IgG increment/mean daily dose in immunoglobulin replacement therapy in primary antibody deficienciesMary Lucas, Martin Lee, Eric Oksenhendler, et al.
Presse Medicale (Paris, France : 1983)|May 20, 2006
[Adult-onset primary hypogammaglobulinemia]Claire Fieschi, Marion Malphettes, Lionel Galicier, et al.
Pageof 18